Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
| Brand name | NIACIN |
| Generic name | NIACIN |
| Active ingredient(s) | NIACIN |
| Distributed by / for | Lannett Company, Inc., Philadelphia, PA 19136 |
| NDC | 62175-322-46 |
| Full product label | Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46. |
| Recalling firm | Lannett Company Inc. |
| Distribution | Nationwide within the United States |
| Quantity | 3984 bottles |
| Recall initiated | 2026-05-27 |
| Report date | 2026-06-10 |
| Recall completed | — |
| Recall number | D-0584-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Seymour IN United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗